Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

Clinical trial NCT05828082 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05828082
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Metastatic Castration-Resistant Prostate Carcinoma Refractory Prostate Carcinoma Stage IVB Prostate Cancer AJCC v8

Start date: 2023-10-16
Primary completion: 2027-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.